Medicinova Inc cash flow statement
In fiscal 2025, Medicinova Inc's operations generated −$9.8m of cash; it spent $2,899 on capital projects, leaving free cash flow of −$9.8m.
Cash flow statement
| Fiscal year | 2012Dec 2012 | 2021Dec 2021 | 2023Dec 2023 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|
| Cash from operations | −12 | −9 | −7 | −10 | −9 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 1 | 2 | 1 | 1 | 1 |
| Capital spending | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −12 | −9 | −7 | −10 | −9 |
| Free cash flow after stock pay | −13 | −11 | −8 | −11 | −10 |
| Share buybacks | −0 | — | — | — | — |
| Shares issued | 1 | — | — | 0 | — |
| Quarter | 2021 Q4Dec 2021 | 2023 Q3Sept 2023 | 2023 Q4Dec 2023 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −3,639 | −1,372 | −499 | −2,306 | −1,703 | −2,017 | −3,470 | −1,920 |
| Depreciation and amortisation | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 5 |
| Stock-based pay | −757 | 219 | −237 | 205 | 158 | 181 | 408 | 177 |
| Capital spending | 0 | 3 | −0 | 0 | 3 | 0 | 11 | 0 |
| Free cash flow | −3,639 | −1,374 | −499 | −2,306 | −1,706 | −2,017 | −3,481 | −1,920 |
| Free cash flow after stock pay | −2,882 | −1,593 | −262 | −2,511 | −1,864 | −2,197 | −3,889 | −2,097 |
Compare with peers
- Shattuck Labs, Inc. cash flow
- Longeveron Inc. cash flow
- Dare Bioscience, Inc. cash flow
- Cartesian Therapeutics, Inc. cash flow
- Absci Corp cash flow
Head to head: MNOV vs STTKLGVN vs MNOVDARE vs MNOV
More: Biotechnology stocks compared, Health Care sector, rankings of US companies